Anti-HCV related to HCV PCR and risk factors analysis in a blood donor population of Central Brazil Anticorpo anti-HCV relacionado a detecção do HCV por PCR e análise de fatores de risco em uma população de doadores de sangue do Brasil Central

Data concerning HCV infection in Central Brazil are rare. Upon testing 2,350 voluntary blood donors from this region, we found anti-HCV prevalence rates of 2.2% by a second generation ELISA and 1.4% after confirmation by a line immunoassay. Antibodies against core, NS4, and NS5 antigens of HCV were...

Full description

Bibliographic Details
Published in:	Revista do Instituto de Medicina Tropical de São Paulo
Main Authors:	R. M. B. Martins, B. O. M. Vanderborght, C. D. Rouzere, C. L. Santana, C. O. Santos, D. N. Mori, R. G. Ferreira, C. F. T. Yoshida
Format:	Article
Language:	English
Published:	Universidade de São Paulo (USP) 1994-12-01
Subjects:	HCV Anti-HCV PCR Risk factors ALT Anti-HBc Blood donors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651994000600005

Similar Items

Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients Anticorpos contra os antígenos não estrutural c100/3 e estrutural core do vírus da hepatite C (HCV) em pacientes de hemodiálise
by: C.F.T. Yoshida, et al.
Published: (1993-08-01)

Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-Campinas Prevalence of HBsAg, anti-HBc and anti-HCV in the blood donors of "Hemocentro-Campinas"
by: Fernando Lopes Gonçales Júnior, et al.
Published: (1993-02-01)

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
by: Tuğrul Himmetoğlu, et al.
Published: (2007-07-01)

The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey
by: Bülent Dabanlıoğlu, et al.
Published: (2024-01-01)

Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Rosini Nilton, et al.
Published: (2003-01-01)

Hepatites pós-transfusionais na cidade de Campinas, SP, Brasil: II. Presença dos anticorpos anti-HBc e anti-HCV em candidatos a doadores de sangue e ocorrência de hepatites pós-transfusionais pelo vírus C nos receptores de sangue ou derivados Post-transfusional hepatitis in the city of Campinas, SP, Brazil: II- Presence of anti-HBc and anti-HCV antibodies in blood donors and occurrence of post-transfusional hepatitis C virus in recipients of blood or derivates
by: Fernando Lopes Gonçales Júnior, et al.
Published: (1993-02-01)

The Case of anti-HCV Negative Chronic Hepatitis C
by: A. L. Rossina, et al.
Published: (2015-12-01)

A clinical, epidemological, laboratorial, histological and ultrasonographical evaluation of anti-HCV EIA-2 positive blood donors Avaliação clínica, epidemiológica, laboratorial, histológica e ultrassonográfica de doadores de sangue anti-HCV EIA-2 positivos
by: Fernando L. GONÇALES JR, et al.
Published: (2000-06-01)

Assessment of HCV Infection in Suspected Orphans Newborns by Real-Time PCR and HCV-Core Ag-Elisa
by: Marzieh Jamalidoust, et al.
Published: (2015-08-01)

Kan vericilerde HBsAg, anti-HCV, anti-HIV ve Sifilis seroprevalansı
by: Mustafa Altındiş, et al.
Published: (2011-03-01)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
by: Daniel Sepúlveda-Crespo, et al.
Published: (2024-08-01)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

Viral Load of HBV and HCV Correlation to Torque Teno Virus (TTV) Co-Infection in Iraqi Patients
by: Layla F. Ali
Published: (2024-09-01)

Sustained virological response according to the type of early virological response in HCV and HCV/HIV
by: Paulo R. Lerias de Almeida, et al.
Published: (2010-04-01)

Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)

Bir Üniversite Hastanesi Laboratuvarında Çalışılan Örneklerde HBs Ag, Anti-HCV, Anti- HIV Seropozitiflik Oranları
by: Emel Sesli Çetin, et al.
Published: (2016-12-01)

The prevalence of hepatitis B infection and anti‐HCV antibody in patients with diabetes mellitus
by: Malihe Naderi, et al.
Published: (2025-09-01)

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
by: Yue Chen, et al.
Published: (2016-11-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania
by: Camelia Sultana, et al.
Published: (2024-08-01)

HCV Reactivation in a Patient with Hepatocellular Carcinoma Due to Sorafenib: A Case Report
by: Cheng J, et al.
Published: (2024-02-01)

IS ONLY REQUESTING AN ANTI-HCV TEST SUFFICIENT FOR HEPATITIS C SCREENING?
by: Rabia Deniz, et al.
Published: (2024-07-01)

Göz Kuruluğu Şikayetiyle Başvuran Sjögren Sendromlu Hastalarda Anti-HCV Seroprevalansının Araştırılması
by: Esmeray Mutlu Yılmaz, et al.
Published: (2023-06-01)

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience
by: Andrea Marino, et al.
Published: (2021-12-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

Advancing high-throughput anti-HCV drug screening: a novel dual-reporter HCV replicon model with real-time monitoring
by: Kanokwan Chitsombat, et al.
Published: (2025-01-01)

Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach
by: Elena Zocca, et al.
Published: (2024-03-01)

External quality assessment for dual detection of HBsAg and anti-HCV in serum
by: Nguyen Thi Minh Thuan, et al.
Published: (2022-01-01)

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile
by: Emiliano Dalla, et al.
Published: (2022-02-01)

Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi Hastanesi Kan Donörlerinde HCV, HIV ve HBV Seroprevalansı
by: Uğur Tüzüner, et al.
Published: (2017-04-01)

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis
by: Daniel Sepúlveda-Crespo, et al.
Published: (2025-05-01)

Antivirals against HCV infection: the story thus far
by: Ahmad Adebayo Irekeola, et al.
Published: (2022-02-01)

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01)

HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination
by: Christos Thomadakis, et al.
Published: (2024-05-01)

Molecular Evaluation of Viral load and Genotype of HCV in Acute and Chronic HCV Patients in Kirkuk City
by: Israa Saadoon, et al.
Published: (2019-03-01)

Elimination of HCV in Russia: Barriers and Perspective
by: Vasily Isakov, et al.
Published: (2022-04-01)

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
by: Daniel Fuster, et al.
Published: (2021-04-01)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
by: Robert Flisiak, et al.
Published: (2022-02-01)

Prevalence of anti HCV infection in patients with beta-thalassemia in Isfahan-Iran
by: Behrooz Ataei, et al.
Published: (2012-01-01)